Kamal Syed T 4
4 · American Renal Associates Holdings, Inc. · Filed Mar 13, 2020
Insider Transaction Report
Form 4
Kamal Syed T
DirectorPresident
Transactions
- Award
Common Stock
2020-03-13+7,614→ 709,606 total
Footnotes (1)
- [F1]Reflects the acquisition of performance-based restricted stock originally granted on March 9, 2018. On March 13, 2020, the Compensation Committee of the Board of Directors determined that certain performance conditions had been satisfied. These shares remain subject to time-based vesting conditions and will vest on March 9, 2021.